These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17661729)

  • 41. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study).
    Cimminiello C; Arpaia G; Polo Friz H; Boracchi P; Marano G; Spezzigu G; Visonà A
    Vasa; 2015 Sep; 44(5):371-9. PubMed ID: 26317257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypertension in peripheral arterial disease.
    Clement DL; De Buyzere ML; Duprez DA
    Curr Pharm Des; 2004; 10(29):3615-20. PubMed ID: 15579058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical management of claudication.
    Ratchford EV
    J Vasc Surg; 2017 Jul; 66(1):275-280. PubMed ID: 28533077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of disability in peripheral arterial disease: new drugs.
    Hiatt WR
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):227-31. PubMed ID: 15379614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peripheral arterial disease: medical care and prevention of complications.
    Dawson DL; Hiatt WR; Creager M; Hirsch AT
    Prev Cardiol; 2002; 5(3):119-30. PubMed ID: 12091754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of chronic peripheral arterial disease.
    Antignani PL
    Curr Vasc Pharmacol; 2003 Jun; 1(2):205-16. PubMed ID: 15320844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there a role for oral anticoagulant therapy in patients with peripheral arterial disease?
    Cosmi B; Palareti G
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):269-73. PubMed ID: 15379620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombotic therapy in peripheral artery disease.
    Foley TR; Waldo SW; Armstrong EJ
    Vasc Med; 2016 Apr; 21(2):156-69. PubMed ID: 26823456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TASC II section F on revascularization in PAD.
    Norgren L; Hiatt WR; Harris KA; Lammer J;
    J Endovasc Ther; 2007 Oct; 14(5):743-4. PubMed ID: 17924742
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN; Modrall JG
    Semin Vasc Surg; 2007 Mar; 20(1):10-4. PubMed ID: 17386359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Office management of peripheral arterial disease.
    Aronow WS
    Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statins and peripheral arterial disease: potential mechanisms and clinical benefits.
    Alnaeb ME; Alobaid N; Seifalian AM; Mikhailidis DP; Hamilton G
    Ann Vasc Surg; 2006 Sep; 20(5):696-705. PubMed ID: 16841271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical practice. Intermittent claudication.
    White C
    N Engl J Med; 2007 Mar; 356(12):1241-50. PubMed ID: 17377162
    [No Abstract]   [Full Text] [Related]  

  • 58. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
    Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
    Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis.
    Basili S; Raparelli V; Vestri A; Di Tanna GL; Violi F
    Thromb Haemost; 2010 Apr; 103(4):766-73. PubMed ID: 20174763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rehabilitation Therapy in Peripheral Arterial Disease.
    Aggarwal S; Moore RD; Arena R; Marra B; McBride A; Lamb B; Martin BJ; Stone J
    Can J Cardiol; 2016 Oct; 32(10 Suppl 2):S374-S381. PubMed ID: 27692118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.